NCT06614465Active, not recruiting
Multimodal Rehabilitation Programme on Epigenetic Biomarkers, Quality of Life, Sexual Function and Muscle Strength in Women With Dyspareunia and Endometriosis.
Effect of a Multimodal Rehabilitation Programme on Epigenetic Biomarkers, Quality of Life, Sexual Function and Muscle Strength in Women With Dyspareunia and Endometriosis: Protocol for a Randomised Controlled Trial.
Source: ClinicalTrials.gov · Last updated 22 May 2025
Brief summary (registry, in English)
This study aims to evaluate the impact of a multimodal rehabilitation programme on epigenetic biomarkers in blood, quality of life, sexual function and pelvic floor muscle strength and endurance in women with dyspareunia and endometriosis.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 126 (estimated)
- First submitted
- 24 Sept 2024
- Start date
- 8 Jan 2025
- Primary completion date
- 31 Jan 2026
- Lead sponsor
- Clínica INEBIR
- Diseases
- Endometriosis
- NCT number
- NCT06614465
What you commit to
- Study type: Interventional
- Planned participants: 126
- From 8 Jan 2025 to the primary completion date, 31 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- A neurological, oncological or autoimmune disease that prevents the participant from performing exercise.
- A diagnosis of severe psychiatric or neurological disorders that do not allow the participant to follow orders.
Other
- Any type of pathology that prevents the participant from performing exercise.
Who the study is looking for
- Women diagnosed with endometriosis
- Women with dyspareunia and chronic pelvic pain
- Ability to communicate fluently verbally and in writing in the language of the research team, in this case Spanish.
- Approval to participate in the study by your regular gynaecologist who is part of your diagnosis and treatment.
Age in the registry: 18 years to 55 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universidad Pablo de Olavide Coordinator of this site? Confirm its status | Seville | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.